We have developed a preclinical tau model of psychotic AD, expressing the P301L human mutant tau gene associated with human tauopathy [56], together with the deletion of the catechol-o-methyltransferase gene (COMT), in order to drive dopamine neurotransmission [57]. The gene discussed is MAPT; the disease is tauopathy.